Gastrointestinal symptoms - Diarrhea, constipation, abdominal discomfort, vomiting Reduced appetite - While this contributes to weight loss, some people find it makes eating adequate nutrition challenging Fatigue - Some individuals report feeling more tired, particularly in the first few weeks Injection site reactions - Redness, itching, or mild discomfort at injection sites (for injectable formulations) Most side effects are dose-dependent and tend to improve as the body adjusts
Some patients find side effects intolerable and discontinue treatment
Richie JP Jr, Nichenametla S, Neiber W, et al
Exenatida Los GLP-1RA entraron a la fase clnica por primera vez por medio de la exenatida, la cual es una forma recombinante de la exendina-4, con una secuencia homloga del 53% con el GLP-1, que se administra de forma subcutnea dos veces al da (b.i.d.)
Quality Standards & Analytical Testing At USA PEPTIDE SCIENCES , laboratory data integrity and compound reproducibility are the fundamental core of our manufacturing operations
Track not only body weight, but also progress in push-ups, squats, and deadlifts as part of your assessment